Skip to content

A trial of neuroprotective vitamin D in traumatic brain injury patients

Investigating the effect of neuroprotective vitamin D on Traumatic Brain injury patients

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20191026045243N2
Enrollment
84
Registered
2019-12-23
Start date
2019-10-22
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral trauma. Intracranial injury

Interventions

Intervention 1: Intervention group: All patients have vitamin D levels above 30. In the first group, daily VDH is administered for 5 days after admission and in the second group, the control group is

Sponsors

Sari University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: All patients admitted to the emergency department and then transferred to the neurosurgery ward All patients admitted to the emergency department and then transferred to the ICU ward

Exclusion criteria

Exclusion criteria: Patients with brain death Equal degree of vigilance Patients hospitalized for less than 5 days Penetrating brain injuries Accompanying severe lesions Severe lesions other than brain injuries such as hemothorax or hemo-peritoneum or any injury requiring rapid surgery and no opportunity for neurological examination in the early stages. itamin D deficiency according to the standard amount reported. And less than 30 ng and more than 60 ng / ml

Design outcomes

Primary

MeasureTime frame
Level of consciousness. Timepoint: Baseline and 7 and 90 days. Method of measurement: Glasgow level of consciousness.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSajad Shafiee

Sari University of Medical Sciences

sajad.shafiee@gmail.com+98 11 3336 1630

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026